HealthBeacon Launches COVID-19 Services for ‘At Risk’ Patients

May 06, 2020

Irish Digital Health Company Adapts Services Helping Patients on Injection Therapy Access Critical Medications

Posted by

HEALTHBEACON LAUNCHES COVID-19 SERVICES FOR ‘AT RISK’ PATIENTS

Irish Digital Health Company Adapts Services Helping Patients on Injection Therapy Access Critical Medications

Now Available to Laya Healthcare Members

[Dublin, Ireland., May 5, 2020] – HealthBeacon medication adherence technology company, has launched a new Covid-19 support offering for patients on injectable therapies which is now available to laya healthcare’s 600,000 members.

HealthBeacon has developed the world’s first Injection Care Management System for patients that self-administer injectable medication in their homes. HealthBeacon eases the burden of managing patients’ injectable medications from home through their Smart Sharps Bin Technology.

During this time of crisis, it is critical that people with chronic conditions continue to take their medications as prescribed by their healthcare professionals while maintaining social distancing and avoiding unnecessary exposures. For this reason, the HealthBeacon Injection Care Management System is being expanded to offer additional services to further support individuals in their homes.

The enhanced HealthBeacon offering, now available to laya healthcare members includesvirtual care support, coordination of medication delivery, medical waste collection, and home monitoring with the HealthBeacon Smart Sharps Bin. This service will reduce the number of visits to the pharmacy and hospitals for those ‘at-risk’ while ensuring patients will continue to take critical medications.

Jim Joyce, CEO HealthBeacon said; “We are delighted that laya healthcare has agreed to cover this service for their members during these unprecedented times, it is critical to adapt and innovate to ensure continued support to patients.  Digital health technology has a huge role to play during COVID-19 and we want to ensure vulnerable patients are able to access critical medications.”

John McCall, Director of Claims and Provider Relations at laya healthcare welcomed the innovative support provided by HealthBeacon to its members “Members who need to regularly inject themselves at home will welcome this new service we’re now offering as part of our enhanced healthcare benefits available at no additional cost until the end of June 2020. It’s just another way we’re looking after our members, always.

ABOUT HEALTHBEACON

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%. For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

See all Member News